Biotechnology FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement – Compass Pathways (NASDAQ:CMPS), Cybin (AMEX:CYBN) Read more